News

$APAAF InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has filed an independent technical report for its PCH ionic adsorption clay (“IAC”) project located in Goiás, Brazil. The PCH MRE report was prepared in accordance with National Instrument 43-10 (“NI 43-101”). Titled “Technical Report on the Maiden Mineral Resource Estimate for the PCH Project, State of Goiás, Brazil,” the report indicated no material differences from results disclosed in the company’s press release released last month. The company noted that the report was coauthored by independent qualified persons under NI 43-101, including Yann Camus, Peng; Marc-Antoine Laporte, PGeo, MSc; and Sarah Dean, PGeo. “The PCH MRE Report has outlined both exceptional grade and volume across both Target IV and Buriti zones, which cover a total area of approximately 480 hectares,” said Appia Rare Earths & Uranium president Stephen Burega in the press release. “Within Target IV, Appia has identified a high-grade zone with an inferred resource totaling 13.5 Mt at an average grade of 7307 parts per million (‘PPM’) TREO. . . . The data generated from the first 300 drill holes at PCH has provided our team with a strong geological signature to track and confirm additional high-grade mineralization at newly identified ionic adsorption clay targets across the remaining tenements, which encompass a very large area of over +40,000 hectares. The phase II auger drilling program is currently well underway, and we look forward to reporting on results as data becomes available.”

To view the full press release, visit https://ibn.fm/59ygl

About Appia Rare Earths & Uranium Corp.

Appia is a publicly traded Canadian company in the rare earth element and uranium sectors. The company is currently focusing on delineating high-grade, critical rare earth elements and gallium on the Alces Lake property, as well as exploring for high-grade uranium in the prolific Athabasca Basin on its Otherside, Loranger, North Wollaston and Eastside properties. The company holds the surface rights to exploration for 94,982.29 hectares (234,706.35 acres) in Saskatchewan. The company also has a 100% interest in 13,008 hectares (32,143 acres), with rare earth element and uranium deposits over five mineralized zones in the Elliot Lake Camp, Ontario. Lastly, the company holds the right to acquire up to a 70% interest in the PCH Ionic Adsorption Project, which is 40,963.18 hectares in size and located within the Goiás State of Brazil. For more information about the company, please visit www.AppiaREU.com.

NOTE TO INVESTORS: The latest news and updates relating to APAAF are available in the company’s newsroom at https://ibn.fm/APAAF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida

SOBRsafe (NASDAQ: SOBR), providers of next-generation, transdermal alcohol-detection solutions, has signed a hardware/software agreement with a four-facility behavioral health provider in Florida; this agreement is one of sixteen new accounts that SOBRsafe has signed in Q1 2024. According to the announcement, SOBRsafe’s SOBRcheck(TM) will replace breathalyzers for frontline screening and allow expanded monitoring abilities for the health provider, which provides a full continuum of care, from inpatient detoxification and residential treatment to outpatient services. The announcement noted that the provider has already installed SOBRcheck in each of its four facilities. “The customer historically used breathalyzers for select check-ins but felt these legacy devices were too inefficient and invasive for uniform entry screening,” said SOBRsafe director of commercial development Eddie Kilroy in the press release. “With SOBRcheck, the provider can verify the absence of alcohol in just 10 seconds or less, in a humane and cost-effective manner. The customer is streamlining operations with automatic results reporting, and electronic records searchable by individual and location. Switching to SOBRcheck has empowered them to enhance and expand their screening protocols, while likely reducing attempts to subvert the testing process.”

To view the full press release, visit https://ibn.fm/Uftll

About SOBR Safe Inc.

SOBRsafe offers an advanced transdermal (touch-based) technology that detects and instantaneously reports in real time the presence of alcohol as emitted through a user’s skin — no breath, blood or urine sample is required. Alcohol misuse is the fourth-leading cause of preventable death in America and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive, inefficient, unhygienic and unconnected. There has to be a better way. Enter SOBRsafe. With a powerful backend data platform, SOBRsafe provides next-generation, passive-detection technology for the behavioral health, judicial and consumer markets, as well as for licensing and integration. The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). SOBRsafe is creating a culture of prevention and support. For more information about SOBRsafe, visit www.SOBRsafe.com.

NOTE TO INVESTORS:The latest news and updates relating to SOBR are available in the company’s newsroom athttp://ibn.fm/SOBR

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M

Longeveron (NASDAQ: LGVN) is a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. The company today announced its entry into definitive agreements for the exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its Class A common stock having an exercise price of $2.35 per share, originally issued in October 2023 and April 2024. Gross proceeds to Longeveron from the exercise of the existing warrants are expected to be approximately $6.2 million, prior to deducting placement agent fees and estimated offering expenses payable by the company. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

To view the full press release, visit https://ibn.fm/Jqzkq

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease, and Aging-related Frailty. For more information about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at http://ibn.fm/LGVN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People

A recently published review has found that social vulnerability and frailty worsen as individuals age. When both are present, these conditions result in a considerably heightened decline in cognitive and physical function as well as mortality risk.

So, what is frailty?

Theoretically, frailty is defined as a state of heightened vulnerability resulting from declines associated with age that is clinically recognizable. These declines often compromise an individual’s ability to cope with acute stressors, with researchers noting that frailty is common among older people.

While advancements in modern medicine have significantly improved life expectancy of humans beyond natural limits, frailty remains a public health and clinical concern worldwide.

What did the investigators focus on?

For their review, the researchers looked into social vulnerability prevalence in people with frailty and vice versa. They also assessed the longitudinal and possibly bidirectional link between social vulnerability and frailty, while also estimating the outcomes and impacts of these conditions’ comorbidity.

They began by collating the outcomes of 130 observational studies that looked into the bidirectional links between social vulnerability and frailty. All publications were obtained from the following online scientific repositories: Web of Science Core Collection, MEDLINE, PsycINFO, Scopus, and the Cumulative Index to Nursing and Allied Health Literature.

The period of study ran from Jan. 1, 2021, to April 28, 2023.

What did the researchers discover?

The researchers determined that frailty was more commonly linked to social vulnerability, with 90% of the studies linking frailty to decreased social participation and another subset linking it to increased loneliness. The review also observed a link between frailty and increased social association, social frailty and decreased perceived social support. In addition, the investigators noted that some studies observed links between physical and social frailty.

In their report, the investigators stated that their objective was to inform public health policymakers and clinicians to consider both social vulnerability and frailty when trying to manage either. They explained that while both conditions were distinct with their pathologies and symptoms, they were closely interrelated. They added that having either condition greatly increased the risk of developing the other.

People who presented with both conditions were also found to depict considerably higher mortality risks as well as cognitive and physical functional declines in comparison to individuals with only one of the aforementioned conditions. The review is registered under International Prospective Register of Systematic Reviews while its methodology was designed in accordance with PRISMA guidelines. Its findings were reported in “The Lancet Healthy Longevity” journal.

Enterprises such as Longeveron Inc. (NASDAQ: LGVN) are focusing on developing treatments targeting people suffering from aging-related frailty so that their quality of life can improve and the additional health risks they face due to frailty can be reduced.

NOTE TO INVESTORS: The latest news and updates relating to Longeveron Inc. (NASDAQ: LGVN) are available in the company’s newsroom at https://ibn.fm/LGVN

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$CIPI Green-Energy Projects Face Financing Woes Amid High Interest Rates

After experiencing unprecedented growth that saw the number of renewable energy projects increase several times over, green-energy projects could potentially face a capital crunch due to high interest rates. Solar and wind project installations may be at an all-time high, but several reputable publications predict that several factors, including high interest rates, could make it difficult for renewable energy projects to access funding and impact green-energy commodity prices in the future.

Several years of cost reductions and legislative support, as well as an explosion of investor interest, directed massive investment into green energy and resulted in significant wind- and solar-power development across the globe. Projections from the International Energy Agency show that the world’s solar-energy output will continue to rise at an average of 25% annually at least until the end of the decade.

Despite these lofty predictions, the businesses behind solar- and wind-energy projects may struggle to access much-needed capital in the future. News sources report that a new set of complications such as higher financing costs as well as higher interest rates outside the Chinese market are set to strain project developers and manufacturers.

This issue could be particularly problematic because green-energy projects typically have low operational costs but require large upfront costs. These projects are prone to price disruptions and are more likely to have higher financing costs due to rising interest rates in linchpin nations such as the United States. The U.S. Federal Reserve has raised benchmark interest rates for several consecutive months, and experts predict that the group won’t lower these rates until the second half of the year.

Some experts are also afraid of an uncontrolled transition to green energy leading to blunders as renewable-energy providers fight to gain funds for infrastructure and sustainable energy from the government through legislation such as the Inflation Reduction Act or the Bipartisan Infrastructure Law.

To prevent such blunders, the local governments in the country should plan their green-energy transitions meticulously by creating compelling business cases, choosing the best sites and ensuring the maintenance of critical infrastructure such as transmission lines. Fortunately, long-term projections for renewable-based commodities are largely bullish.

The Renewables Monthly Metals Index’s (MMI) decline recently slowed down and started to flatten out while the MMI saw an overall drop of 0.36%, an indication of month-on-month sideways price action. On the other hand, the Grain Oriented Electrical Steel MMI saw greater heavy downward month-on-month price action and fell by 13.26%.

Grain-oriented electric steel (GOES) prices have been subject to increased volatility over the past few years due to a variety of factors that have affected supply dynamics on a global scale. As these prices are typically available in intermittent intervals, GOES are more likely to experience exacerbated price volatility, logistical challenges, plant closures and manufacturing capacity limits that lead to price spikes and supply shortages.

The decentralized green-energy generation solutions being commercialized by companies such as Correlate Energy Corp. (OTCQB: CIPI) could come in handy in lowering the cost outlays of setting up new projects geared at availing clean energy.

NOTE TO INVESTORS: The latest news and updates relating to Correlate Energy Corp. (OTCQB: CIPI) are available in the company’s newsroom at https://ibn.fm/CIPI

About GreenEnergyStocks

GreenEnergyStocks (“GES”) is a specialized communications platform with a focus on companies working to shape the future of the green economy. GreenEnergyStocks is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GES is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, GES brings its clients unparalleled recognition and brand awareness. GES is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
Editor@GreenEnergyStocks.com

GreenEnergyStocks is powered by IBN

Thursday, April 18th, 2024 News No Comments

$FNICF Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects

  • Electric vehicles are expected to account for over 50% of automobile sales in 2040, driving a six-fold increase in global nickel demand
  • Fathom Nickel has looked to capitalize on the world’s ambitions for a carbon-neutral future through the exploration and development of two promising nickel deposits located within Canada’s Saskatchewan province
  • The site of historic exploratory and mining activity during the 1960’s, initial exploration work across both the Albert Lake and Gochager Lake projects have found great potential in terms of resource and mineral yields

Forecasts suggest that by 2040, electric vehicles (“EVs”) will comprise over 50 percent of annual passenger vehicles sales, as manufacturers and customers transition to cleaner forms of transportation in a bid to limit and curb the harmful emissions currently contribution to global warming (https://ibn.fm/Ni1Wi). In turn, the surge in electric vehicle manufacturing and sales have significantly escalated the demand for crucial raw material inputs such as nickel within the electric vehicle supply chain; a recent report has suggested that global nickel demand is poised to increase six-fold as of 2030, largely because of the burgeoning electric vehicle market. Whilst this scenario has presented an array of growth prospects within the nickel mining and refining sectors, it has also presented its own challenges, namely in terms of the environmental impact of mining operations as well as geopolitical issues related to supply chain security.

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Calgary-based Canadian natural resource development and exploration company has sought to cater to the ongoing energy transition through the exploration and development of high-grade nickel sulfide developments. Nestled within the prolific Trans Hudson Corridor in Canada’s Saskatchewan province, Fathom Nickel’s two sites, namely – the Albert Lake project and the Gochager Lake project respectively have played host to historic artisan mining operations, with Fathom Nickel now seeking to build upon the prior activity.

Albert Lake, a broad geographic expanse totaling over 90,000 hectares in site was previously host to the historic Rottenstone Mine in the mid-1960’s (https://ibn.fm/JQd4d). Whilst it only produced 26,000 tons during the five-year period in which the mine was active, its output was prolific in terms of its mineral grades: 3.28% nickel, 1.83% copper and 9.63g/t of platinum + palladium + gold (“3PE”). Whilst historic reserves on the site were estimated at approximately 50,000 tons, ongoing drilling by Fathom Nickel has recently uncovered a similar and promising mineralization pattern approximately 500 meters west-northwest from the original Rottenstone deposit, in an area called the Bay-Island Trend; the findings have reinforced the company’s belief that Rottenstone was just one occurrence within a larger magmatic nickel system, with the Albert Lake area’s potential far beyond the boundaries of what has been explored thus far.

A 5,000-hectare site optioned by Fathom Nickel in September 2022; the Gochager Lake project has since been expanded to 22,000 hectares on account of the area’s potential. Building upon historic exploratory work carried out on site in 1967, Fathom Nickel drilled 9 holes totaling 2,893 meters in 2023; initial results were extremely promising. Fathom drillhole GL23003 was featured in Northern Miner Magazine as the 8th best nickel intercept drilled worldwide in 2023. At 58.2 meters in length, initial analysis uncovered 1.11% nickel content, 0.38% copper and 0.11% cobalt.

The prominent role played by nickel within the EV battery manufacturing supply chain has underscored the mineral’s importance in helping achieve a carbon-neutral feature. Nevertheless, and with demand for nickel on the rise, additional pressure has been heaped upon nickel’s market dynamics, particularly around pricing and supply chain stability – the latter exacerbated by the uneven global distribution of nickel resources, a potentially point of conflict in the event of any geopolitical instability. As such, Fathom Nickel is playing an increasingly important role within the nickel and global energy transition movement on account of both, its promising assets as well as its geographic location amidst an increasingly fragmented global environment.

For more information, visit the company’s website at www.FathomNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to FNICF are available in the company’s newsroom at https://ibn.fm/FNICF

About MiningNewsWire

MiningNewsWire (“MNW”) is a specialized communications platform with a focus on developments and opportunities in the Global Mining and Resources sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled recognition and brand awareness.

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$RFLXF Malaysian Company to Transform Agricultural Waste into Graphite in Nevada

Last week, Graphjet Technology (NASDAQ: GTI) revealed its plans to construct an artificial graphite manufacturing facility in Nevada. The company develops patented technologies for the sustainable production of graphene, graphene-based anode materials and graphite from agricultural waste.

The facility will be the first-of-its-kind in the United States and will have the capacity to recycle up to 30,000 metric tons of agricultural waste, with an annual production aim of 10,000 metric tons of artificial graphite. This is expected to be able to support production of batteries to power over 100,000 electric cars annually.

Graphjet Technology’s Malaysia plant, which is to be commissioned later this year, will also process palm kernel shells into hard carbon, then ship them to Nevada. This does away with one step in the production process and reduces time required to produce graphite in Nevada. The company anticipates commissioning the Nevada facility and commencing production by 2026.

Nevada is an ideal location for the plant because it is located near a number of automotive original equipment manufacturers (“OEM”) and battery manufacturers that will need a considerable amount of graphite for future production of electric vehicle batteries. Graphjet Technology CEO and cofounder Aiden Lee stated that the company was well-positioned to become the leading graphite source for America and was thrilled to venture into the market with Nevada as its launch pad.

Lee added that the company was already in discussions to enter into offtake agreements for its products and was focused on bringing commercial production online as soon as possible.

Graphjet plans to create local green-energy jobs in Nevada and invest in the region while building the next-generation graphite production facility. This manufacturing facility is expected to create more than 500 high-skilled labor positions. Additionally, the company expects to invest more than $150 million into the Nevada facility and is already evaluating strategic and financing options to finance the plant.

Graphjet expects to offer cost-effective, environmentally friendly and sustainable solutions that can support the needs of leading automotive and battery OEMs while also addressing the increasing demand for graphite.

Currently, the company’s technology produces only 2.95 CO2 emissions per every kilogram of graphite. This is in comparison to 9.2 CO2 emissions produced for every kilogram of natural graphite in Canada and 17 CO2 emissions produced for every kilogram of synthetic graphite in China. The technology primarily relies on palm kernel shells from palm seed oil production to produce artificial graphite and single layer graphene.

Other companies, such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF), are focusing on extracting natural graphite to address the market that prefers the natural form over the synthetic version of this critical mineral.

NOTE TO INVESTORS: The latest news and updates relating to Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) are available in the company’s newsroom at https://ibn.fm/RFLXF

About MiningNewsWire

MiningNewsWire (“MNW”) is a specialized communications platform with a focus on developments and opportunities in the Global Mining and Resources sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled recognition and brand awareness.

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., announced that results from a phase 2 Visionary-MS long-term extension (“LTE”) study have been presented at the 2024 American Academy of Neurology (“AAN”) annual meeting. The data, which demonstrates improved clinical, functional and structural outcomes associated with daily oral dosing of CNM-Au8 30 mg. for up to three years of treatment, was presented by Dr. Michael Barnett, MBBS, FRACP, FRCP, PhD, from the University of Sydney. The new long-term results from the clinical trial indicate the repair and remyelinating effects of CNM-Au8 treatment in patients, results that further enhance the trial’s findings from the double-blind period of the study. Barnett noted that results from the VISIONARY-MS trial “provide clear impetus” for a definitive phase 3 study. “Observing such a profound clinical benefit with corresponding improvements in physiologic measures utilizing a mechanism that does not target immune system modulation has never been demonstrated in prior multiple sclerosis trials,” said Clene head of medical Dr. Benjamin Greenberg in the press release. “This is a very exciting data set that gives hope to the millions of people who are suffering from this disabling disease.”

To view the presentation, visit https://ibn.fm/za50w

To view the full press release, visit https://ibn.fm/Fc50M

About Clene Inc.

Clene and its wholly owned subsidiary, Clene Nanomedicine, is a late-clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8(R) is an investigational, first-in-class therapy that improves the survival and function of central nervous system cells via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8 is a federally registered trademark of Clene Nanomedicine. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$PXMD InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has received an urgent request from the Ministry of Health (“MOH”) of Malawi requesting emergency access to IV suramin. According to the announcement, Malawi officials requested the suramin in efforts to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used in that region of Africa; the drug is used specifically to treat the most severe form of African sleeping sickness. Last week, PaxMedica completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin) in preparation for a future NDA submission to the U.S. Food and Drug Administration (“FDA”) as an orphan designated drug. With that in mind, PaxMedia has brought this emergency request to the FDA’s attention to determine potential impact, if any, on the company’s development program and NDA submission plans for PAX-101. “Receiving this request from the Ministry of Health of Malawi serves to emphasize, not only the challenging situation faced by the countries in the most vulnerable zone for the fatal disease, TBr HAT, it speaks to the continued need for suramin as the standard of care in treating stage 1 of the infection, using what’s known as the Malawi dosing protocol, which they have used in an effort to save lives in that region for nearly 100 years,” said PaxMedica chair and CEO Howard Weisman in the press release. “[The] FDA has agreed that having more than one global manufacturer of drugs like suramin could provide public health benefit by creating multiple supply chains and would help ensure a steady supply of the drug product. . . . PaxMedica is in the process of responding to the Malawi Ministry of Health’s request and is in contact with regulatory authorities in both the U.S. and Malawi with an intention to help with today’s emergency, as well as to work with the FDA to determine the best path forward to submit the PAX-101 NDA for regulatory approval, as well as to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide PaxMedica resources to help ensure a steady supply of suramin to these endemic regions.”

To view the full press release, visit https://ibn.fm/NIaog

About PaxMedica Inc.

PaxMedica is a forward-looking, clinical-stage biopharmaceutical firm specializing in cutting-edge, anti-purinergic drug therapies (“APT”) aimed at addressing a range of challenging neurologic disorders. The company’s comprehensive portfolio encompasses a spectrum of conditions, including neurodevelopmental disorders such as autism spectrum disorder (“ASD”) as well as other critical areas within the neurology field. Additionally, the company intends to provide the rest of the world with an additional, reliable source of suramin, the accepted standard of care for Stage 1, Trypanosoma Brucei Rhodesiense. PaxMedica is dedicated to the continuous development and evaluation of its pioneering program, PAX-101, an intravenous suramin formulation that lies at the heart of the company’s efforts, particularly focused on innovative ASD treatment solutions. The company’s ongoing research initiatives not only prioritize the needs of ASD patients but also extend to exploring potential therapeutic applications for related conditions. For more information about the company, visit www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$FRGT InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Appointed as Solave’s Logistics Solutions Provider for Cross-Border Operations

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has announced that it was selected by Grupo Solave for cross-border logistics services. Solave, recognized for its leadership in the blue agave market and a reputable tequila producer for notable brands, aims to benefit from optimized logistics and supply chain efficiency through Fr8App’s platform. “We are thrilled to take on the role of logistics solutions provider for Solave, applying our advanced platform and extensive network to meet their specific logistics needs,” said Javier Selgas, CEO of Fr8App. “Tequila is one of the most popular spirits in the world, and sales are expected to grow approximately 6% annually over the coming decade. We are proud to serve the marketplace of this iconic spirit within Mexican heritage and are positioned to support the logistic requirements of its growth.”

To view the full press release, visit https://ibn.fm/N2SwT

About Freight Technologies Inc.

Freight Technologies (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. Its wholly owned subsidiary, Freight App Inc. (“Fr8App”), is a B2B cross-border shipping marketplace in the USMCA region powered by AI and machine learning. Focused on making shipping transparent and efficient, Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road (“OTR”) shipping. Fr8App uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via innovative technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions. The company is headquartered in Houston, Texas. For more information, please visit Fr8Technologies.com.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments

$FNGR InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Agreements to Add Charging Terminal Access for Users of Growing Da Ge App

FingerMotion (NASDAQ: FNGR), a mobile services and data company, through its contractually controlled entity, Shanghai JiuGe Information Technology Co. Ltd., is facilitating the expanded use of the Da Ge app. According to the announcement, the company is entering into arrangements with certain electric vehicle (“EV”) charging station providers in China that will allow owners of electric vehicles who have subscribed to the Da Ge app to locate and charge their cars. The arrangements are with Jiangsu YKC and Shanghai Anyo Charging Technology Co. Ltd, which operates more than 400,000 charging terminals for electric vehicles. According to the announcement, the Da Ge app will integrate with both Jiangsu YKC and Anyo Charging apps, allowing Da Ge users to access direct connections at these terminals; the agreement should provide Da Ge access to the growing Chinese EV market. FingerMotion launched the Da Ge app earlier this year. The app, which currently has 650,000 subscribers, is designed to connect subscribers with independent service stations providing car washing, fine car detailing, paint protective films, color changing and maintenance; so far 20,000 car-care service stations have been onboarded with the app with increased numbers projected by the end of the year. “We are excited to collaborate with both Jiangsu YKC and Anyo Charging and believe this will be a very positive mutually beneficial arrangement,” said FingerMotion CEO Martin Shen in the press release. “This is a big step in further monetizing our Da Ge app and giving our subscribers a product that really facilitates the use of electric charging stations in major cities across China. . . . Future Da Ge product offerings may include the company’s Top Up and Recharge service, car accessories, and possibly health and auto insurance, which could double our total subscriber numbers by FY 2026.”

To view the full press release, visit https://ibn.fm/pckpm

About FingerMotion Inc.

FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China. As the user base of its primary business continues to grow, the company is developing additional value-added technologies to market to its users. The vision of the company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the company to onboard larger customer bases. FingerMotion eventually hopes to serve more than 1 billion users in the China market and expand the model to other regional markets. For more information about the company, please visit www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at http://ibn.fm/FNGR

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

Thursday, April 18th, 2024 News No Comments